Infectious disease medicine is method of distinctive the presence of foreign antigen/organism with the assistance of assorted diagnostic tools. Communicable disease conditions area unit extremely current in below developed regions because of lack of awareness for private hygiene, lowest aid expenditures and absence of economical physician services. The high incidence of infectious diseases across rising economies formulate a significant share in overall market. This has grabbed the attention of in vitro diagnostic device manufactures to invest into rising economies. These corporations area unit taking efforts to develop and commercialize price effective tools for the communicable disease designation. Presently, the gold standard tests available for microorganism infections and sexually transmitted illness designation have major market share. However, these test are expected to replace by molecular techniques in future.
How Big is The Global Infectious Disease Diagnostics Market?
The Global Infectious Disease Diagnostics Market is expected to exceed more than US$ 27.5 Billion by 2028 at a CAGR of 5% in the given forecast period.
The major driving factors of Global Infectious Disease Diagnostics Market are as follows:
The restraining factors of Global Infectious Disease Diagnostics Market are as follows:
The Global Infectious Disease Diagnostics Market is segmented on the lines of its technology, product, application, End-user and regional. Based on product Analysis segmentation it covers Instruments & Analyzers, Assays and Reagents and Services & Software. Based on technology it covers Traditional Diagnostic Techniques and Molecular diagnostics. Based on End user it covers Hospitals Laboratories, Reference Labs, Physician office Labs, Academics (Academic Medical Centers/Research Labs, University Labs) and others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point of Care, Self-Testing). Based on application segmentation it covers Hepatitis B, Hepatitis C, Aids, Tuberculosis (TB), Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV) Infection, Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection and Others (Influenza, Ebola, Typhoid, Malaria, Dengue). Global Infectious Disease Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Infectious Disease Diagnostics Market.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Infectious Disease Diagnostics Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of Global Infectious Disease Diagnostics Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton Dickinson & Company, Cepheid Inc., Abbott Laboratories, BioMerieux, Hologic Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Affymetrix, Alere Inc., and DiaSorin others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Infectious Disease Diagnostics Market has been segmented as below:
By Product Analysis:
By Application Analysis:
By Technology Analysis:
By End-User Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Infectious Disease Diagnostics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Infectious Disease Diagnostics Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Ultraviolet disinfection equipment Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Crackdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Market to Grow at A Modest Rate
4.2 Market, By Product
4.3 Global Market, By Application
4.4 Global Market, By Technique
4.5 Global Market, By End User
4.6 Market, By Geography
4.7 Lifecycle Analysis, By Region
5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market, By Product
5.2.2 Market, By Application
5.2.2 Market, By Technique
5.2.3 Market, By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence Rate of Infectious Diseases to Drive the Growth of Idd Market
5.3.1.2 Slow Turnaround Time of the Current Diagnostic Cycle Has Created Demand for Rapid Diagnostic Procedures
5.3.1.3 New Rapid Diagnostic Tests Hold Promise for the Improved Management and Control of Infectious Diseases
5.3.1.4 Increased Funding to Propel the Idd Market
5.3.2 Restraints
5.3.2.1 Rising Healthcare Costs Limits the Usage of Novel Infectious Disease Diagnostic Techniques
5.3.2.2 Complex Regulatory Framework to Delay Approvals of New Diagnostic Tests
5.3.3 Opportunities
5.3.3.1 Huge Growth Prospects in Developing Countries
5.3.3.2 Advances in Research and Development for Better Diagnostic Procedures to offer New Growth Opportunities
5.3.3.3 Personalized Medicine
5.3.4 Challenges
5.3.4.1 Dearth of Trained Professionals Restricting the Appropriate Use of New Diagnostic Tests
5.3.4.2 Difficulties Regarding Reimbursement for New Diagnostic Tests May Hamper Innovation
5.3.5 Winning Imperatives
5.3.5.1 Shift in the Focus From Centralized Laboratories to Decentralized Point-of-Care Testing Augmenting the Growth of Idd Market
5.3.6 Burning Issues
5.3.6.1 Global Regulatory Environment Restricting the Clearance and Marketing of Infectious Disease Diagnostic Products
6 Industry Insights
6.1 Introduction
6.2 Supply Chain Analysis
6.2.1 Key Influencers
6.3 Pest Analysis
6.3.1 Political Factors
6.3.2 Economical Factors
6.3.3 Social Factors
6.3.4 Technological Factors
6.4 Industry Insights
6.5 Strategic Benchmarking
6.5.1 New Product Launches
7 Infectious Disease Diagnostics Market, By Product
7.1 Introduction
7.2 Instruments & Analyzers
7.3 Consumables
7.3.1 Assays and Reagents
7.4 Services & Softwares
8 Infectious Disease Diagnostics Market, By Application
8.1 Introduction
8.2 Hepatitis B
8.3 Hepatitis C
8.4 Aids
8.5 Tuberculosis (TB)
8.6 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
8.7 Human Papillomavirus (HPV) Infection
8.8 Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection
8.9 Others (Influenza, Ebola, Typhoid, Malaria, Dengue)
9 Infectious Disease Diagnostics Market, By Technique
9.1 Introduction
9.2 Traditional Diagnostic Techniques
9.2.1 Immunodiagnostics
9.2.2 Microscopy
9.2.3 Biochemical Characterization
9.3 Molecular Diagnostics
9.3.1 PCR
9.3.2 INAAT
9.3.3 Hybridization
9.3.4 DNA Sequencing & NGS
9.3.5 Microarray
9.3.6 Others
10 Infectious Disease Diagnostics Market, By End User
10.1 Introduction
10.2 Hospitals Laboratories
10.3 Reference Labs
10.4 Physician office Labs
10.5 Academics (Acadmic Medical Centers/Research Labs, University Labs)
10.6 Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point of Care, Self Testing)
11 Geographic Analysis
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (ROW)
12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Battle for Market Share: New Product Launches Was the Key Strategy
12.4 New Product Launches
12.5 Agreements, Partnerships, and Collaborations
12.6 Acquisitions
12.7 Expansions
12.8 Other Developemnts
13 Company Profile
13.1 Abbott Laboratories
13.1.1 Business Overview
13.1.2 Product Portfolio
13.1.3 Key Strategy
13.1.4 Recent Developments
13.2 Becton, Dickinson & Co.
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Key Strategy
13.2.4 Recent Developments
13.3 Biomérieux
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Key Strategy
13.3.4 Recent Developments
13.3.5 SWOT Analysis
13.4 Bio-Rad Laboratories
13.4.1 Business Overview
13.4.2 Products & Services
13.4.3 Key Strategy
13.4.4 Recent Developments
13.5 Alere, Inc.
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Key Strategy
13.5.4 Recent Developments
13.6 Thermo Fisher Scientific, Inc.
13.6.1 Products & Services
13.6.2 Key Strategy
13.6.3 Recent Developments
13.7 Siemens Healthcare
13.7.1 Business Overview
13.7.2 Key Strategy
13.7.3 Recent Developments
13.8 Roche Diagnostics
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategy
13.8.4 Recent Developments
13.9 Danaher Corporation
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Key Strategy
13.9.4 Recent Developments
13.10 Johnson and Johnson
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategy
13.10.4 Recent Developments
The Global Infectious Disease Diagnostics Market has been segmented as below:
By Product Analysis:
By Application Analysis:
By Technology Analysis:
By End-User Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
